Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss

ClinicalTrials.gov ID: NCT07503210

Public ClinicalTrials.gov record NCT07503210. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 9, 2026, 6:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of NNC0487-0111 s.c. Once Weekly in Participants With Obesity Who Have Reached Target Dose During run-in Period (AMAZE 12)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111 (the treatment being tested) or Placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.

Study identification

NCT ID
NCT07503210
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
600 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 20, 2026
Primary completion
Jun 5, 2028
Completion
Jul 3, 2028
Last update posted
Aug 26, 2026

2026 – 2028

United States locations

U.S. sites
13
U.S. states
11
U.S. cities
12
Facility City State ZIP Site status
Pinnacle Research Group LLC Anniston Alabama 36207 Active, not recruiting
Diablo Clinical Research, Inc. Walnut Creek California 94598 Active, not recruiting
Florida Inst For Clin Res LLC Orlando Florida 32825 Active, not recruiting
Endeavor Health Skokie Illinois 60077 Active, not recruiting
Midwest Inst For Clin Res Indianapolis Indiana 46260 Active, not recruiting
Medication Mgmnt, LLC_Grnsboro Greensboro North Carolina 27405 Active, not recruiting
PMG Research of Wilmington LLC Wilmington North Carolina 28401 Active, not recruiting
UPA Ctr Weight and Eating Dis Philadelphia Pennsylvania 19104 Active, not recruiting
Clinical Res Collaborative Cumberland Rhode Island 02864 Active, not recruiting
North Texas Endocrine Center Dallas Texas 75231 Not yet recruiting
UT Southwestern Med Cntr Dallas Texas 75390-9302 Active, not recruiting
Selma Medical Associates Winchester Virginia 22601-3834 Active, not recruiting
Rainier Clin Res Ctr Inc Renton Washington 98057 Active, not recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 59 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07503210, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 26, 2026 · Synced Sep 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07503210 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →